New research has identified a possible mechanism for blood clotting issues in some COVID-19 patients.
A new study suggests a possible mechanism for the elevated presence of blood clots in COVID-19 patients.
The research, published in the journal Circulation, may help clinicians develop more effective treatments for COVID-19.
The sudden emergence and rapid global spread of the new coronavirus have meant clinical responses have focused on supporting those with severe infections, supplemented with emergency societal interventions, such as widespread social distancing, to reduce infection rates.
Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.
Because SARS-CoV-2 is a new virus, previous treatments developed for similar strains will not necessarily work. Instead, possible therapies need to be identified in theory, tested and, once safe, implemented in the real world. However, this all takes time.
SARS-CoV-2 is mainly a danger because for some patients — particularly those with certain underlying health conditions, compromised immune systems, or who are later in life — a type of severe acute respiratory syndrome can develop, similar to pneumonia.
COVID-19, the disease caused by the virus, makes a person’s lungs inflamed.